SURESNES, France–( ORGANIZATION CABLE)– HEPTA Medical (” HEPTA”), an exclusive clinical tool business devoted to giving a reliable, secure, and minimally-invasive thermal ablation treatment for early-stage lung cancer cells, today introduced it has actually efficiently increased EUR5.7 M in the initial close of its Collection A financing round. The financial investment was led by BPI France with the engagement of M&L Medical care and Clery IG. This funding round will certainly allow HEPTA to start the United States regulative authorization procedure for t.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/hepta-medical-secures-e5-7-million-series-a-led-by-bpi-france-to-advance-minimally-invasive-lung-cancer-treatment/
